Introduction
Pharmaceutical companies generate enormous amounts of information during clinical research. Every clinical trial can produce data about patients, diseases, treatments, biomarkers, endpoints, adverse events, protocols, and outcomes.
The challenge is that this information is rarely stored in one place.
Clinical trial data may exist across databases, laboratory systems, electronic records, documents, archives, data warehouses, and legacy applications. Even when organizations have access to these systems, understanding the relationships between the information can be difficult. Rear-View Mirror to Training Data: How Archived Clinical Trial Data Is Teaching AI to Design the Next Trial
This is where a clinical trial knowledge graph can provide significant value.
A knowledge graph connects data points through meaningful relationships. Instead of treating clinical information as isolated records, it can connect concepts such as patients, diseases, treatments, trials, biomarkers, clinical sites, and outcomes.
For pharmaceutical AI, this contextual layer can make complex clinical information easier to discover, analyze, and reuse.
When combined with properly governed historical clinical trial data, knowledge graphs can help organizations move from fragmented data toward a more connected and AI-ready research environment.
What Is a Clinical Trial Knowledge Graph?
A clinical trial knowledge graph is a data structure that represents clinical research information as interconnected entities and relationships.
For example:
Patient → Participated In → Clinical Trial
Clinical Trial → Evaluated → Treatment
Treatment → Targets → Disease
Patient → Experienced → Outcome
Biomarker → Associated With → Treatment Response
These relationships provide context around individual data points.
Traditional databases are excellent for storing structured records.
Knowledge graphs add another capability:
They help represent how information is connected.
This can be especially useful when pharmaceutical researchers need to investigate relationships across multiple studies and datasets.
Why Clinical Trial Data Is Difficult to Connect
Clinical research data is often fragmented.
A pharmaceutical organization may have:
Historical trial data in archives
Current studies in clinical trial systems
Laboratory information in separate databases
Research documents in content repositories
Real-world evidence in external datasets
Patient information across different platforms
Each system may use different structures and terminology.
This makes cross-study analysis difficult.
For example, a researcher may want to find all previous trials involving patients with a particular disease who received a particular treatment and exhibited a specific biomarker profile.
Finding that information may require searching multiple systems and manually connecting the results.
A knowledge graph can provide a unified relationship layer over these sources.
Connecting Historical Clinical Trial Data
Historical clinical trials contain valuable research knowledge.
However, the information can become difficult to reuse when it is stored in legacy systems or disconnected archives.
The Solix article Rear-View Mirror to Training Data: How Archived Clinical Trial Data Is Teaching AI to Design the Next Trial explains how archived clinical trial data can be transformed into AI-ready training information through processes such as data harmonization, terminology reconciliation, patient-level linking, feature engineering, cohort filtering, and outcome matching.
A knowledge graph can complement this process by representing the relationships among the resulting data assets.
Instead of simply storing a historical dataset, organizations can create connections between:
Clinical trials
Patients
Treatments
Diseases
Outcomes
Biomarkers
Protocols
Data sources
This makes historical knowledge easier to discover and analyze.
How a Knowledge Graph Works
Consider a simplified example.
A historical clinical trial contains:
Trial A
It evaluates:
Drug X
For:
Disease Y
The trial includes patients with:
Biomarker Z
Some patients demonstrate:
Treatment Response
A knowledge graph can represent these relationships as connected nodes.
This allows researchers to ask complex questions such as:
Which previous trials evaluated Drug X in patients with Disease Y who had Biomarker Z?
Instead of manually searching multiple datasets, a graph-based system can traverse the relationships between these entities.
- Connecting Patients and Clinical Trials
Knowledge graphs can connect patient-level information with the studies in which patients participated.
For example:
Patient → Enrolled In → Trial
Patient → Has Disease → Disease
Patient → Received → Treatment
Patient → Has Biomarker → Biomarker
Patient → Experienced → Outcome
These relationships can help researchers understand patient populations across multiple studies.
Patient privacy and appropriate access controls remain essential when representing sensitive clinical information.
- Connecting Diseases and Treatments
A pharmaceutical knowledge graph can connect diseases with treatments evaluated across different studies.
Researchers can investigate:
Which treatments were tested?
In which diseases?
In which patient populations?
What outcomes were observed?
Which biomarkers were associated with response?
This can provide a broader view of historical research.
- Connecting Biomarkers With Outcomes
Biomarkers are increasingly important in precision medicine.
A knowledge graph can represent relationships between:
Biomarkers
Patient characteristics
Treatments
Clinical responses
Adverse events
Researchers can then explore whether particular biomarkers appear repeatedly across studies.
AI models can use this contextual information to identify potential patterns.
- Connecting Clinical Trial Protocols
Clinical trial protocols contain important information about study design.
A knowledge graph can connect protocol information with:
Eligibility criteria
Patient populations
Treatments
Endpoints
Study phases
Clinical sites
Outcomes
This can help researchers compare previous trial designs.
For example, researchers could examine how eligibility criteria changed across multiple studies involving the same disease.
- Supporting AI Clinical Trial Design
AI can analyze large amounts of information.
But AI becomes more useful when it has access to context.
A knowledge graph can provide relationships that help AI understand connections between clinical concepts.
For example:
Disease → Trial → Patient Population → Treatment → Biomarker → Outcome
This creates a contextual representation of historical research.
AI systems can potentially use these relationships to support:
Trial design
Patient cohort analysis
Recruitment
Treatment research
Outcome analysis
Trial feasibility
The goal is not to allow AI to make independent clinical decisions.
Instead, knowledge graphs can provide researchers with a richer information foundation.
- Supporting Patient Cohort Discovery
Finding appropriate patient cohorts is an important part of clinical research.
Researchers may want to identify patients with combinations of characteristics.
For example:
Disease A + Biomarker B + Previous Treatment C + Specific Outcome
Traditional databases can perform this type of query, but complex relationships across multiple systems can be difficult to manage.
Knowledge graphs can represent these connections naturally.
This can help researchers explore relationships between patient characteristics and historical trial outcomes.
- Supporting Synthetic Control Research
Historical clinical trial data can potentially support external or synthetic control populations in appropriate study designs.
Knowledge graphs can help researchers discover patients and studies that share relevant characteristics.
For example:
Disease → Historical Trial → Patient Cohort → Treatment → Outcome
Researchers can use these relationships to identify potentially relevant historical populations for further statistical and clinical evaluation.
The graph itself does not determine whether a population is scientifically valid.
It helps researchers discover and connect the information needed for evaluation.
- Connecting Archived Data With Current Research
One of the strongest opportunities is connecting historical and current clinical research.
Historical studies provide accumulated knowledge.
Current studies generate new evidence.
A knowledge graph can create relationships across both.
For example:
Historical Trial → Similar Disease → Similar Patient Population → Current Trial
This can help researchers understand how new research relates to previous work.
It can also reduce the risk of valuable institutional knowledge remaining isolated inside legacy archives.
- Improving Clinical Data Discovery
Researchers often spend significant time finding the data they need.
A knowledge graph can make discovery more intelligent.
Instead of searching only for keywords, researchers can explore relationships.
For example, a researcher searching for a specific treatment might discover:
Related clinical trials
Relevant diseases
Patient cohorts
Biomarkers
Outcomes
Protocols
Associated datasets
This creates a more contextual research experience.
- Supporting Data Lineage
Knowledge graphs can also represent relationships between data sources and downstream datasets.
For example:
Clinical Trial Database → Historical Dataset → Harmonized Dataset → AI Training Dataset
These relationships can provide visibility into how data moves through the organization.
This complements traditional data lineage systems.
For pharmaceutical AI, understanding the origin and transformation of data is critical.
Knowledge Graphs and Data Provenance
A knowledge graph can also represent provenance relationships.
For example:
Dataset → Derived From → Clinical Trial
Variable → Defined By → Data Standard
Cohort → Created From → Dataset
AI Model → Trained On → Dataset Version
These connections can help researchers understand how an AI dataset was created.
This is especially valuable when historical clinical data has passed through multiple transformations.
Knowledge Graphs Can Help Reduce Data Silos
Data silos do not necessarily disappear when organizations move information to a centralized platform.
Different systems can still have different structures and meanings.
A knowledge graph can act as a semantic layer connecting information across these systems.
The organization can preserve source systems while creating a connected view of the information.
This can reduce the need for researchers to manually reconcile relationships across disconnected applications.
The Role of Ontologies and Semantic Standards
Knowledge graphs depend on meaningful concepts.
Pharmaceutical organizations can use ontologies and standardized vocabularies to represent concepts consistently.
These can help define relationships between:
Diseases
Drugs
Biomarkers
Clinical events
Outcomes
Patient characteristics
Semantic standards make it easier for AI systems and researchers to interpret relationships across different datasets.
Building a Clinical Trial Knowledge Graph
Organizations can approach implementation in stages.
Step 1: Identify important clinical entities
Determine which concepts should be represented.
Examples include:
Patients
Trials
Diseases
Treatments
Biomarkers
Outcomes
Step 2: Identify data sources
Map where the information currently exists.
Step 3: Standardize terminology
Create consistent representations of clinical concepts.
Step 4: Integrate relevant datasets
Connect historical and current data sources.
Step 5: Define relationships
Establish meaningful connections between entities.
Step 6: Apply governance
Implement privacy, security, access, and quality controls.
Step 7: Add provenance
Track the origin and transformation history of information.
Step 8: Enable AI and analytics
Use the connected information to support approved research applications.
Data Governance Remains Essential
A knowledge graph does not remove the need for governance.
Clinical information represented in a graph may still contain sensitive data.
Organizations need appropriate controls for:
Privacy
Access
Data quality
Provenance
Security
Data usage
Retention
Auditability
The graph should therefore operate within the organization's broader clinical data governance framework.
Challenges of Clinical Knowledge Graphs
Knowledge graphs can provide significant benefits, but implementation has challenges.
Data integration
Organizations need to connect many different data sources.
Terminology differences
Clinical concepts may be represented differently across studies.
Data quality
Incorrect relationships can produce misleading results.
Privacy
Patient-level information requires strong protection.
Complexity
Large clinical environments can contain millions of relationships.
Governance
Organizations need policies for creating and maintaining graph data.
Maintenance
Knowledge graphs need to evolve as new clinical studies and information become available.
AI and Knowledge Graphs Together
Knowledge graphs and AI can complement each other.
AI can identify patterns in large datasets.
Knowledge graphs can provide structured relationships and context.
Together, they can create a more intelligent research environment.
For example:
Clinical Data → Knowledge Graph → Contextual Relationships → AI Analysis → Researcher Review
This approach can help researchers explore complex clinical questions more efficiently.
The Future of Pharmaceutical Knowledge Graphs
Knowledge graphs may become increasingly important as pharmaceutical companies build AI-driven research environments.
Future systems could connect:
Clinical trials
Real-world evidence
Patient populations
Genomics
Biomarkers
Treatments
Outcomes
Research publications
Regulatory information
This could create a continuously evolving pharmaceutical knowledge network.
AI systems could then use this contextual information to support increasingly sophisticated research applications.
From Data Silos to Connected Clinical Intelligence
The transformation can be summarized as:
Fragmented Clinical Data
↓
Data Discovery
↓
Data Harmonization
↓
Data Governance
↓
Knowledge Graph
↓
Connected Clinical Knowledge
↓
AI Analysis
↓
Research Intelligence
This represents a shift from simply storing information to understanding relationships across information.
Conclusion
A clinical trial knowledge graph can provide an important connective layer for modern pharmaceutical research.
Historical clinical trials contain valuable information, but that value can remain hidden when data is fragmented across legacy systems, archives, databases, and documents.
Knowledge graphs can connect patients, diseases, treatments, biomarkers, trials, protocols, and outcomes into a contextual network.
When combined with AI-ready clinical data, strong governance, data provenance, and appropriate privacy controls, this connected information can support more intelligent research workflows.
The larger opportunity is to turn historical clinical research into a reusable source of organizational knowledge.
Instead of asking only:
Where is the data?
Researchers can begin asking:
How is this data connected to everything else we know?
That shift—from data discovery to relationship discovery—can help pharmaceutical organizations build a stronger foundation for AI-driven clinical research.
For a deeper look at how archived clinical trial data can become AI training data for future clinical trial design, explore the Solix article Rear-View Mirror to Training Data: How Archived Clinical Trial Data Is Teaching AI to Design the Next Trial.
Frequently Asked Questions
- What is a clinical trial knowledge graph?
A clinical trial knowledge graph is a connected data structure that represents relationships between clinical research entities such as patients, trials, diseases, treatments, biomarkers, protocols, and outcomes.
- How do knowledge graphs help pharmaceutical companies?
Knowledge graphs can help pharmaceutical organizations connect information across fragmented systems and make relationships between clinical data easier to discover and analyze.
- Can knowledge graphs connect historical clinical trial data?
Yes. Knowledge graphs can connect information from historical studies with other clinical datasets, provided the data is appropriately integrated, standardized, governed, and protected.
- How can AI use a clinical knowledge graph?
AI can use the relationships and contextual information represented in a knowledge graph to support applications such as cohort discovery, clinical trial analysis, patient recruitment, and research intelligence.
- What is the difference between a database and a knowledge graph?
A database primarily stores structured records, while a knowledge graph emphasizes relationships between entities and concepts.
- Can knowledge graphs help with clinical trial design?
Yes. They can connect historical protocols, patient populations, treatments, biomarkers, and outcomes to help researchers analyze previous studies when designing future trials.
- How do knowledge graphs support patient cohort discovery?
Knowledge graphs can connect multiple patient characteristics, treatments, diseases, biomarkers, and outcomes, allowing researchers to explore complex combinations of clinical information.
- Can knowledge graphs support synthetic control research?
They can help researchers discover relevant historical patients and trials that may be evaluated for external control populations. Statistical and clinical validation is still required.
- Why is data provenance important in a clinical knowledge graph?
Provenance helps researchers understand where information originated, how it was transformed, and which datasets contributed to a particular relationship or analytical result.
- How do knowledge graphs reduce clinical data silos?
They can create a connected semantic layer across different data sources, allowing researchers to discover relationships without requiring every source system to use exactly the same structure.
- What role does data governance play in knowledge graphs?
Governance provides controls for privacy, security, access, quality, provenance, data usage, and maintenance of information represented in the graph.
- What are the main challenges of building a pharmaceutical knowledge graph?
Major challenges include data integration, terminology differences, data quality, privacy, scalability, governance, and ongoing maintenance.
- Can knowledge graphs make archived clinical data more valuable?
Yes. By connecting archived information with related clinical concepts, studies, treatments, and outcomes, knowledge graphs can make historical research easier to discover and reuse.
- What is the future of clinical knowledge graphs?
Future clinical knowledge graphs may connect clinical trials with real-world evidence, genomics, biomarkers, treatments, outcomes, publications, and other research information to provide richer context for AI-powered pharmaceutical research.
Top comments (0)